Join our webinar on March 29 at 14:00 UK (9AM ET/15:00 EU) and hear from our VP EMEA Frederic Menardo, Managing Consultant SME Christopher Stickel, and Senior Director Executive SME Christoph Krähenbühl.
Exploring the challenges and benefits of product data management across Regulatory, Safety, and Supply Chain
The implementation of Identification of Medicinal Products (IDMP) in the EU is driving efforts towards structured data submissions and digitization of product information. The upcoming requirement has significant impact to data management and surrounding business processes in the Life Sciences industry.
Although driven as a Regulatory requirement, there is significant global impact and overlap with initiatives in Pharmacovigilance and Serialization. There are also significant potential benefits as well.
Unfortunately, many companies operate with these functions in silos – partly due to the different pace that the requirements are being rolled out in different areas. This causes problems with data consistency and master data management, and limits the potential benefits of standardization. This webinar will discuss the similarities and differences in product tracking requirements across Regulatory, Pharmacovigilance, and Serialization, and will provide insights in to how you can best kickstart a master data strategy, and attain both tactical and strategic advantage.
Key Points:
Speakers:
Date Wednesday, January 26
Speakers:
Counterfeiting methods are becoming ever more sophisticated. As counterfeiters seek to exploit products entering new markets with fewer controls, serialisation compliance and brand security remain an ongoing challenge and the strength of pharma supply chains is frequently tested.
With patient safety and brand integrity a critical concern, managing and mitigating the growing risks of counterfeiting, tampering and trademark infringement in day-to-day operations is an essential component of safe and effective pharma product management.
In an age where the protection, security and traceability of medicines is constantly under the spotlight, pharma companies of all sizes must rise to the challenge of developing watertight systems and processes across their entire operation.
In this insightful hour-long FREE webinar, global pharma compliance specialists Excellis Health Solutions (part of NNIT) will explore these risks in greater detail, highlighting the key considerations every pharma company must address in 2022.
To view a copy of this webinar, please click here.
Managing EMVS EU-FMD alerts in a timely and GMP-compliant way is a legal obligation for every pharma manufacturer selling to the European market.
Over two years after go-live, it’s clear that this remains a challenge, and the volume of alerts – despite being reduced overall – will remain significant over the long-term.
Across the broad range of customers for whom Excellis operates the Alerts Management Service, we observe an alert rate of 3 alerts per 1,000 packs – making EU-FMD alerts a daily occurrence.
Every MAH therefore needs a solid, reliable, quality-compliant process, operating during EU pharmacy working hours to achieve the mandated response times – regardless of whether the alert’s source is caused by the MAH or more common supply chain factors beyond their control.
Join our Webinar to learn:
To view a copy of this webinar, please click here.
The Brazilian Authorities (ANVISA) have set out requirements in line with the National Medicine Control System (SNCM). Join Excellis as we talk about what that means for Pharma companies, and how you can get ready for the April 2022 deadline.
Date: January 28, 2021
Speakers:
To view a copy of this webinar, please click here.
As a Virtual Pharma company, your primary focus is on the science and finding new ways to meet existing and unmet medical needs; however, there are important steps you need to follow to bring your product to market and achieve success. Commercialising your product successfully relies on how effectively you can leverage what the relevant domain experts can offer.
Presenters:
This webinar will help you identify what to focus on to achieve success based on our deep subject matter expertise.
This webinar discussed:
Presenters
View the recording HERE.
Date: June 10
Excellis Europe has a proven serialization track record with over 150 projects launched, 200 pack lines qualified, 50+ go-lives, 500+ CMOs/3PLs onboarded and 92 validation projects.
We will reveal the five things virtual pharma need to know about getting their product into the European market.
To view a copy of this Webinar, please click HERE.
Date: May 13
As a Virtual Pharma company, your primary focus is on the science and finding new ways to meet existing and unmet medical needs. However, there are important steps you need to follow to bring your product to market and achieve success. Commercializing your product successfully relies on how effectively you can leverage what the relevant domain experts can offer.
This webinar will help you identify what to focus on to achieve success based on our deep subject matter expertise.
To view a copy of this Webinar, please click HERE.
Date: January 10
Pharmaceutical companies who need to ensure supply chain compliance with the Russia regulations now have until 1 July 2020 to do so. The original 1 January 2020 deadline has been pushed back by six (6) months after a legislative development in Russia over the Christmas period.
In this webinar, we will talk about the following:
To view a copy of this Webinar, please click HERE.